Navigation Links
New Paper Reveals Reasons for Payer Discontent with Disease Management
Date:9/8/2008

A thought provoking manuscript addressing key challenges facing the industry.

Nashville, TN (PRWEB) September 8, 2008 -- From pioneering research and profound insight into the inner workings of disease management (DM) comes a thought provoking manuscript addressing key challenges facing the industry. The article is published this month in The Journal of Managed Care Pharmacy.

http://www.amcp.org/data/jmcp/643-649_8055-Final.pdf [Why 2008 May Be The Tipping Point for Disease Management], by disease management research expert Brenda Motheral, BPharm, MBA, PhD, presents a compelling view on why 2008 has been a year of discontent in the disease management industry but could actually pave the way for new business models and competitors.

In the paper, Dr. Motheral explains: "While once the darling of employers and benefit consultants, disease management is now the object of considerable dissatisfaction and growing distrust. Based on industry observation, there seem to be multiple reasons for this disaffection, five of which include lack of: 1) alignment of vendor and client interests, 2) transparency in business arrangements; 3) plausibility in reports of financial and clinical outcomes; 4) rigorous evaluation methodology; and 5) convincing evidence of outcomes improvement."

The goal of this candid commentary is to draw attention to the DM industry's deficiencies while clearly stating that there are short- and long-term solutions to be considered. Here are a few examples outlined in the paper:

  • If still using an opt-out model with limited transparency, plan sponsors can move to an engagement revenue model and require greater detail on engagement and interventions, including call recording.
  • Expand outcome assessments beyond methodologically-weak financial ROIs to include more frequent reporting of key leading clinical indicators that are less susceptible to exaggeration, such as medical compliance.

According to Dr. Motheral: "In today's economy, plan sponsors can no longer afford to purchase disease management services on faith, and without greater evidence of value. To be successful, the new generation of disease management vendors must be much more methodical in determining which individuals to target, how much intervention is really warranted and how to provide customized solutions to address the most important needs of each plan sponsor," .

About CareScientific
Led by Dr. Brenda Motheral, CareScientific is a trusted consulting resource developed to improve the efficiency and effectiveness of disease management, health, wellness and pharmaceutical care programs. To learn more, please visit www.CareScientific.com.

Contact:
Kate Leach
Marketing Communications Consultant
The Agency
575.937.8423
kate @ itstheagency.com

# # #

Read the full story at http://www.prweb.com/releases/2008/09/prweb1303304.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
2. USA TODAY Concludes Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
3. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
4. New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals
5. APC papers in global theme issue on poverty
6. Lost in the middle: author order matters, new paper says
7. Free White Paper Details Hospital Strategies for Meeting Joint Commission Compliance Requirements in the Environment of Care
8. MediNotes EMR Now Interfaces With 76 Practice Management Systems, Allowing More Medical Practices to Replace Their Patients Aging Paper Medical Records
9. Free White Paper From The Beryl Institute Quantifies Bottom-Line Impact of Corporate Culture
10. White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing
11. Thomson Scientific Takes a Fresh Look at Multiauthor Papers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: